Clinical and immunological alterations observed in patients undergoing long-term thoracic duct drainage.
D000328:Adult; D000917:Antibody Formation; D001172:Arthritis, Rheumatoid / Q000276:immunology / Q000628:therapy; D001327:Autoimmune Diseases / Q000276:immunology / Q000628:therapy; D001402:B-Lymphocytes / Q000276:immunology; D003095:Collagen Diseases / Q000628:therapy*; D003882:Dermatomyositis / Q000628:therapy; D004322:Drainage / Q000379:methods; D005260:Female; D006801:Humans; D006968:Hypersensitivity, Delayed / Q000276:immunology; D007111:Immunity, Cellular; D008180:Lupus Erythematosus, Systemic / Q000628:therapy; D008196:Lymph / Q000276:immunology; D008214:Lymphocytes / Q000276:immunology*; D008297:Male; D013601:T-Lymphocytes / Q000276:immunology; D013897:Thoracic Duct / Q000601:surgery*; D013997:Time Factors